180 related articles for article (PubMed ID: 35163097)
1. TRIM37 Promotes Pancreatic Cancer Progression through Modulation of Cell Growth, Migration, Invasion, and Tumor Immune Microenvironment.
Do TT; Yeh CC; Wu GW; Hsu CC; Chang HC; Chen HC
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163097
[TBL] [Abstract][Full Text] [Related]
2. lncRNA NUTM2A-AS1 Targets the SRSF1/Trim37 Signaling Pathway to Promote the Proliferation and Invasion of Breast Cancer.
Ning X; Zhao J; He F; Yuan Y; Li B; Ruan J
Comput Math Methods Med; 2022; 2022():3299336. PubMed ID: 35959349
[TBL] [Abstract][Full Text] [Related]
3. TRIM37 promotes the aggressiveness of ovarian cancer cells and increases c-Myc expression by binding to HUWE1.
Li D; Zhang Z
Arch Biochem Biophys; 2022 Oct; 728():109372. PubMed ID: 35921902
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Tripartite Motif-Containing Protein 37 (TRIM37) Inhibits the Proliferation and Tumorigenesis in Colorectal Cancer Cells.
Zhao P; Guan HT; Dai ZJ; Ma YG; Liu XX; Wang XJ
Oncol Res; 2017 Jan; 25(1):115-122. PubMed ID: 28081740
[TBL] [Abstract][Full Text] [Related]
5. TRIM37 negatively regulates inflammatory responses induced by virus infection via controlling TRAF6 ubiquitination.
Zhao L; Hao Y; Song Z; Fan Y; Li S
Biochem Biophys Res Commun; 2021 Jun; 556():87-92. PubMed ID: 33839419
[TBL] [Abstract][Full Text] [Related]
6. TRIM37 promoted the growth and migration of the pancreatic cancer cells.
Jiang J; Tian S; Yu C; Chen M; Sun C
Tumour Biol; 2016 Feb; 37(2):2629-34. PubMed ID: 26395261
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer.
Przanowski P; Lou S; Tihagam RD; Mondal T; Conlan C; Shivange G; Saltani I; Singh C; Xing K; Morris BB; Mayo MW; Teixeira L; Lehmann-Che J; Tushir-Singh J; Bhatnagar S
Cancer Res; 2020 Nov; 80(21):4791-4804. PubMed ID: 32855208
[TBL] [Abstract][Full Text] [Related]
8. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z
Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622
[TBL] [Abstract][Full Text] [Related]
9. TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner.
Miao C; Liang C; Li P; Liu B; Qin C; Yuan H; Liu Y; Zhu J; Cui Y; Xu A; Wang S; Su S; Li J; Shao P; Wang Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):195. PubMed ID: 34130705
[TBL] [Abstract][Full Text] [Related]
10. TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.
Meitinger F; Ohta M; Lee KY; Watanabe S; Davis RL; Anzola JV; Kabeche R; Jenkins DA; Shiau AK; Desai A; Oegema K
Nature; 2020 Sep; 585(7825):440-446. PubMed ID: 32908304
[TBL] [Abstract][Full Text] [Related]
11. ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-κB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer.
Fu T; Ji K; Jin L; Zhang J; Wu X; Ji X; Fan B; Jia Z; Wang A; Liu J; Bu Z; Ji J
Gastric Cancer; 2021 Jan; 24(1):45-59. PubMed ID: 32572790
[TBL] [Abstract][Full Text] [Related]
12. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
[TBL] [Abstract][Full Text] [Related]
13. TRIM37 Augments AP-2γ Transcriptional Activity and Cellular Localization via K63-linked Ubiquitination to Drive Breast Cancer Progression.
Cui G; Gao Z; Chang S; Narwade N; Chen Y; Poudel B; Lei KMK; Zhang W; Li G; Poon TCW; Cheung E
Int J Biol Sci; 2022; 18(11):4316-4328. PubMed ID: 35864973
[TBL] [Abstract][Full Text] [Related]
14. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
Zheng L; Zhao Z; Rong L; Xue L; Song Y
J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K/Akt signaling pathway.
Tang SL; Gao YL; Wen-Zhong H
Biomed Pharmacother; 2018 Mar; 99():59-64. PubMed ID: 29324313
[TBL] [Abstract][Full Text] [Related]
16. LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression.
Hu X; Xiang D; Xie Y; Tao L; Zhang Y; Jin Y; Pinello L; Wan Y; Yuan GC; Li Z
Oncogene; 2019 Oct; 38(44):7017-7034. PubMed ID: 31409898
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis.
Cai H; Zhao J; Zhang Q; Wu H; Sun Y; Guo F; Zhou Y; Qin G; Xia W; Zhao Y; Liang X; Yin S; Qin Y; Li D; Wu H; Ren D
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167183. PubMed ID: 38657551
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis.
Sun Q; Ye Z; Qin Y; Fan G; Ji S; Zhuo Q; Xu W; Liu W; Hu Q; Liu M; Zhang Z; Xu X; Yu X
Oncogene; 2020 Oct; 39(42):6572-6588. PubMed ID: 32929153
[TBL] [Abstract][Full Text] [Related]
19. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits the proliferation and invasion of ovarian cancer cells by suppressing tripartite motif-containing 37-induced tumor necrosis factor receptor-associated factor 2 ubiquitination.
Zheng Y; Zhang H; Sun H
Cancer Sci; 2022 Nov; 113(11):3776-3786. PubMed ID: 35950370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
